Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
 GILD | Gilead Sciences Inc | $179.5b | $145.74 | 0.0% | 88.0K |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $6.4b | $12.68 | 0.0% | 929.2K |
 NTLA | Intellia Therapeutics, Inc | $1.7b | $12.24 | 0.0% | 104.0K |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $7.41 | 0.0% | 3.9K |
 VOR | Vor Biopharma Inc. Common Stock | $1.1b | $17.99 | 0.0% | 10.7K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.75 | 0.0% | 303.2K |
 IMMX | Immix Biopharma, Inc. Common Stock | $0.8b | $9.51 | 0.0% | 13.4K |
 YDES | YD Bio Limited Ordinary Shares | $0.6b | $5.84 | 0.0% | 1.1K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $1.44 | 0.0% | 102.7K |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $333.9m | $6.88 | 0.0% | 15.6K |
 FATE | Fate Therapeutics, Inc. | $278.0m | $2.24 | 0.0% | 67.3K |
 IPSC | Century Therapeutics, Inc. Common Stock | $277.0m | $1.29 | 0.0% | 11.0K |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $226.9m | $8.53 | 0.0% | 777 |
 NKTX | Nkarta, Inc. Common Stock | $184.4m | $2.26 | 0.0% | 16.7K |
 TARA | Protara Therapeutics, Inc. Common Stock | $180.2m | $2.53 | 0.0% | 11.4K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $130.8m | $0.61 | 0.0% | 4.3M |
 ENGN | enGene Therapeutics Inc. Common Stock | $130.0m | $1.81 | 0.0% | 27.7K |
 ANIX | Anixa Biosciences, Inc. | $102.6m | $3.00 | 0.0% | 14.4K |
 ATRA | Atara Biotherapeutics, Inc | $95.2m | $9.50 | 0.0% | 125 |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $63.5m | $11.93 | 0.0% | 604 |
 ACET | Adicet Bio, Inc. Common Stock | $60.8m | $6.20 | 0.0% | 16.4K |
 CELU | Celularity Inc. Class A Common Stock | $51.9m | $1.52 | 0.0% | 2.2K |
 TVGN | Tevogen Inc. Common Stock | $45.5m | $6.75 | 0.0% | 30 |
 TCRX | TScan Therapeutics, Inc. Common Stock | $21.7m | $0.27 | 0.0% | 13.9K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $20.4m | $0.43 | 0.0% | N/A |
 INAB | IN8bio, Inc. Common Stock | $13.8m | $1.41 | 0.0% | 20 |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $11.0m | $0.94 | 0.0% | 970 |
 SNTI | Senti Biosciences Holdings, Inc. Common Stock | $10.0m | $0.31 | 0.0% | 2.7K |
 LNAI | Lunai Bioworks Inc. Common Stock | $5.9m | $1.11 | 0.0% | 657 |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $4.3m | $0.42 | 0.0% | 221 |
 MBIO | Mustang Bio, Inc. | $3.6m | $0.46 | 0.0% | 270 |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $3.5m | $2.49 | 0.0% | 1.2K |
 CLDI | Calidi Biotherapeutics, Inc. | $2.8m | $1.03 | -1.0% | 1.4K |